SPY378.65+2.95 0.79%
DIA309.32+1.20 0.39%
IXIC13,197.18+198.68 1.53%

Surface Oncology Reports FDA Clearance For SRF617, SRF388 Investigational New Drug Applications to Initiate Phase 1 Trials

Benzinga · 01/27/2020 21:07